Precision Medicine Market Sets 2025 Economic Growth Target with Higher Percent, a Post-COVID 19 Plan

The MarketWatch News Department was not involved in the creation of this content.

According to the 2020 Market Research Future Survey, the analysts saw 12.48% of business growth in the Global Precision Medicine Market 2020 is expected to register. Five months later, in May 2020, as the COVID-19 pandemic spread worldwide, there was less possibility that business was having a favorable impact on a broader note. The analysts further studied that the market can reach a valuation of USD 126.14 Billion by 2025. The entire growth scenario is predicted to take place during the years 2014-2022.

Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @ https://www.marketresearchfuture.com/sample_request/925

Precision Medicine–Boomers & Decliners

The field of precision medicine has made extensive progress with prime discoveries such as microarray/ biochips and single nucleotide polymorphism. These advancements in healthcare have been beneficial for patients to the core of the pharmaceutical industry as well as society. The advent of precision medicine has made researchers understand the method of patients clinical profiles. Human genome research is the future of precision medicine as it owes maximum potential to modify medical treatments for individual patients through the understanding of molecular profiles, genetics, and clinical characteristics in determining the treatment. These factors have made the precision medicine market more robust and stable during the COVID 19 pandemic period.

MRFR’s report presents the factor rising prevalence of cancer to be projected as a booster for personalized cancer diagnostics and therapeutics demands that will leave a positive impact on theprecision medicine market growth. As per a recently published article, in 2018, in the U.S., roughly 1.7 million cases were diagnosed with cancer alone. Apart from this, more factors propelling the growth of this market are escalating online collaborative forums, rising efforts to characterize genes and advancements in cancer biology.

Furthermore, precision medicine applications are chiefly directed toward better treatment against oncological diseases, with an estimated 30% and above market leadership over other segments. According to the data reported in clinicaltrials.gov, the United States and a few European countries are the foremost hubs for conducting and recruiting patient pool for precision medicine applications in oncology globally. The elevated support from the government through funding and rapid growth of genomic analysis might boost the development of the precision medicine market at a fast velocity in the forecast period.

Precision Medicine Market Segment Review

The global precision medicine market has been studied under ecosystem players, sub-markets, and therapeutics.

By the segment of ecosystem players, the global precision medicine market has included diagnostic companies, pharmaceuticals and biotechnology companies, clinical laboratories, and healthcare IT specialists/big data companies. The diagnostic tool companies segment grabbed a market value of USD 16.27 million back in 2017.

By the segment of sub-markets, the market has included molecular diagnostics, companion diagnostics, biomarker-based tests, targeted therapeutics, pharmacogenomics (PGX), and others.

By the segment of therapeutics, the market has included cardiovascular disease (CVD), cancer/oncology, infectious diseases, central nervous system, and others.

Precision Medicine Market Regional Aspect

North America presently leads the market for precision medicine and is expected to prolong its monopoly for upcoming years. In North America, the United States holds the prevalent market share. Former President Barack Obama, back in 2015, unveiled the Precision Medicine Initiative (PMI), a brave new enterprise to revolutionize medicine and generate scientific evidence needed to move the concept of precision medicine into every-day clinical practice.

UK medicine market held a significant share in 2019 and was valued at more than USD 3 billion. The factors such as favorable government initiatives coupled with big data in healthcare and the rising prevalence of cancer have fueled the market growth. Health Europa reveals that in 2018, the UK government invested approximately USD 272.1 million in precision medicine to develop novel diagnostic tools, medical products, and treatments.

Precision Medicine Market Vendors Landscape

The prominent players in the global precision medicine market are Almac Group, Ltd., bioMerieux SA, CETICS Healthcare Technologies GmbH, GlaxoSmithKline Plc (GSK), Johnson & Johnson, Medtronic, Pfizer Inc, BIOBASE GmbH (Subsidiary), Randox Laboratories Ltd, Sanofi Pharma, Teva Pharmaceutical Industries Ltd., Caris Life Sciences, IBM, Intel Corporation, and Precision for Medicine.

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @ https://www.marketresearchfuture.com/reports/precision-medicine-market-925

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

COMTEX_374876319/2582/2020-11-23T04:33:14

Is there a problem with this press release? Contact the source provider Comtex at [email protected] You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Source Article